They apparently don’t understand that the pharmaceutical market is complicated. For every $100 in spending on insulin in 2018, manufacturers received $46.73. The rest went to pharmacy benefit managers ($14.36), insurers ($10.40), pharmacies ($20.42) and wholesalers ($8.09), according to a study last year in the Journal of the American Medical Association.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.